Product Information
MORPHINE SULF ER 200 MG TABLET is a generic product labeled by SpecGx LLC, priced at $2.1267 per EA under NDC 00406832001. Its NADAC has been published 580 times since Nov 28, 2013.
FDA first approved this application on Jul 3, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
SpecGx LLCNDC
00406832001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076438FDA Approved
7/3/2003
TE Code
AB
On Market Since
7/3/2003
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF ER 200 MG TABLET has been published 580 times since Nov 28, 2013, and over the history we have for it it has risen 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1267 per EA |
|---|---|
| All-time high | $4.9951 (Jan 14, 2015) |
| All-time low | $1.6606 (Jun 19, 2024) |
| 52-week high | $2.3835 |
| 52-week low | $1.9746 |
| Median price | $2.6525 |
| Average price | $3.0133 |
| Largest weekly change | +107.1% (Dec 11, 2013) |
| Weeks tracked | 580 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MORPHINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MORPHINE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULF ER 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF ER 200 MG TABLET, manufactured by SpecGx LLC, is $2.1267 per EA (NDC 00406832001), effective Sep 30, 2026.
How has the price of MORPHINE SULF ER 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF ER 200 MG TABLET has risen 17.8%. It has been tracked across 580 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF ER 200 MG TABLET?
Since Nov 28, 2013, the NADAC for MORPHINE SULF ER 200 MG TABLET has ranged from a low of $1.6606 (Jun 19, 2024) to a high of $4.9951 (Jan 14, 2015), with a median of $2.6525 per EA.
Are there cheaper alternatives to MORPHINE SULF ER 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULF ER 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULF ER 200 MG TABLET?
MORPHINE SULF ER 200 MG TABLET (NDC 00406832001) is labeled by SpecGx LLC, and CMS classifies it as a generic product.